VisualMed establishes Latin American subsidiaryMontreal-based VisualMed, a developer of clinical information systems and software, is creating a new company to market and distribute its products in Latin America and the Caribbean. VisualMed
Montreal-based VisualMed, a developer of clinical information systems and software, is creating a new company to market and distribute its products in Latin America and the Caribbean. VisualMed Internation SA will be owned by VisualMed and Conar Business International, a Panamanian venture capital firm. The new company will be headquartered in Panama.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.